Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect
Noritoshi Nagaya(National Cerebral and Cardiovascular Center), Kenji Kangawa(National Cerebral and Cardiovascular Center), Toru Satoh(Kyorin University), Hisayuki Matsuo(National Cerebral and Cardiovascular Center), Shingo Kyotani(National Cerebral and Cardiovascular Center), Toshio Nishikimi(Kyoto University), Masaaki Uematsu(National Cerebral and Cardiovascular Center), Norifumi Nakanishi(National Cerebral and Cardiovascular Center)
Cited by 82
Related Papers
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478